Log in with your email address username.

×

Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Editorial] Vision quest: gene therapy for inherited vision loss

Biomedical research and clinical trials are fundamentally high-stakes endeavours, the results of which are often portrayed in hyperbolic categories. Failed phase 3 trials are called epic disappointments, while successful treatments become game changers or magic bullets. Better still, they receive US Food and Drug Administration (FDA) approval.

email